Mounjaro and Zepbound are the same medicine, tirzepatide, sold under two names. After your last dose the drug clears from your body over about two to three weeks, and the main thing you feel is appetite and food noise returning rather than a new side effect appearing. In the SURMOUNT-4 trial, people who switched from tirzepatide to a placebo saw their weight rise by about 14 percent over the following year, while those who stayed on it kept losing.
So the useful way to think about stopping is not "what will the drug do to me on the way out" but "what happens when the appetite brake comes off". Those are very different questions, and the second one you can plan for.
Mounjaro and Zepbound are the same drug
This trips a lot of people up. Mounjaro is the brand of tirzepatide approved for type 2 diabetes, and Zepbound is the brand of tirzepatide approved for weight management. The molecule is identical. That means everything below applies the same way whether your box said Mounjaro or Zepbound, and it is also why you will not find a separate "Zepbound withdrawal" and "Mounjaro withdrawal". There is one drug.
Tirzepatide acts on two gut hormone receptors, GIP and GLP-1, which together turn down appetite and slow how fast the stomach empties. When the drug leaves, both of those effects fade.
How long tirzepatide stays in your system
Tirzepatide has a half-life of about 5 days, according to the Zepbound label. A half-life is the time it takes for half of the drug in your blood to clear. After roughly five half-lives a medicine is mostly gone, which puts full clearance at about two to three weeks after your last dose.
You will usually notice the change before the drug is fully gone. As the blood level drops through the first week or two, the appetite signal it was holding down starts to come back. People often describe a specific morning when breakfast suddenly feels small, or the afternoon when snacks they had ignored for months look interesting again.
What comes back first: appetite and food noise
The earliest and most reliable change is hunger. Tirzepatide works mainly by reducing how much you want to eat, so when it clears, your natural appetite returns. For many people that includes food noise, the steady mental chatter about food that the medication had quieted. Our explainer on whether food noise is real covers why that chatter is biology, not weak will.
This is the part worth preparing for, because it arrives before any weight change shows on the scale. If your meals had quietly shrunk while on the drug, returning hunger can feel alarming even though it is simply your body asking for a normal amount again. The task is not to fight it but to meet it with structure: protein at each meal, regular timing, and enough sleep, since short sleep raises appetite on its own.
The side effects usually ease, not worsen
Unlike stopping some medicines, there is no recognised tirzepatide withdrawal syndrome. The nausea, reflux, early fullness and constipation that some people live with while on the drug are driven by the slowed stomach emptying, so they tend to settle once the drug clears, not flare up. We walk through the semaglutide version of this in side effects of stopping Ozempic, and the pattern for tirzepatide is the same.
The symptom that is not a classic side effect, and the one to take seriously, is a steady upward move in your weight over several weeks. That is not the drug leaving. It is appetite outrunning your routine, and it is the signal to tighten the routine and, if it keeps climbing, to talk to your prescriber.
What SURMOUNT-4 found after people switched off
The clearest data comes from the SURMOUNT-4 trial in JAMA. Everyone took tirzepatide for 36 weeks and lost an average of 20.9 percent of their body weight. Then half were switched to a placebo without a change in anything else. Over the next 52 weeks, the placebo group regained, ending about 14 percent above where the switch happened, while the group that stayed on tirzepatide lost a further 5.5 percent.
Read that carefully: the regain was an average, not a verdict on any one person. It shows how much of the result the drug itself was holding in place, which is useful to know going in. What it does not show is what happens for someone who stops the drug but keeps a deliberate maintenance routine, because the trial did not test that. Our piece on regaining weight after stopping Zepbound goes through the numbers in more detail, and maintaining weight loss after Mounjaro covers the routine side.
A calm way to watch the first eight weeks
The first two months off tirzepatide are mostly about telling signal from noise, because the scale jumps around while water and digestion settle. The fix is an average rather than any single morning. Weigh in under similar conditions and judge the 7 day rolling average.
This is exactly how OffRamp's Regain Radar works. It compares your 7 day average with your own baseline and only reports drift when that average sits 2 percent or more above baseline on every one of 7 days in a row, with an alert at 4 percent held the same way. With an 80 kg baseline the drift line is 81.6 kg, so one heavy weekend cannot trip it but two quiet weeks of extra eating will. Pair that with your protein floor and a couple of short strength sessions, and if the average does keep climbing, OffRamp can export a weigh-in history as a PDF to bring to your prescriber. The medication decisions stay with them.
